Sympano Overview

  • Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $225K
Latest Deal Amount
  • Investors
  • 2

Sympano General Information


Developer of a vitro diagnostic device designed to cure pneumonia and sepsis. The company's device uses nanotechnology to measure patient biomarkers faster, less expensively and much more sensitively than current standards, enabling doctors to detect pneumonia and sepsis in the first stage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 4640 South West Macadam Avenue
  • Suite 130 East
  • Portland, OR 97239
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sympano Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2017 $225K Completed Startup
1. Accelerator/Incubator 03-Aug-2015 Completed Startup
To view Sympano’s complete valuation and funding history, request access »

Sympano Executive Team (1)

Name Title Board Seat Contact Info
Thomas Barrett MD Founder, Chief Medical Officer and Chief Executive Officer
To view Sympano’s complete executive team members history, request access »

Sympano Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
OTRADI Bioscience Incubator Accelerator/Incubator Minority 000 0000 000000 0
To view Sympano’s complete investors history, request access »